Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

Journal of Hepatology

Volumn 30, Issue 1, 1999, Pages 8-13

  Bellobuono, Antonio ^a   Mondazzi, Luca ^a   Tempini, Silvana ^b   Chiodo, Federico ^b   Magliano, Enrico ^b   Mondini, Chiara ^a   Idéo, Gaetano ^a  

^a S Giuseppe Hospital   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Antiviral therapy; Hepatitis C virus; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS GENOME;

EID: 0032898051     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80002-6     Document Type: Article

References (30)

1. Tinè F, Magrin S, Craxì A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis: a meta-analysis of randomised clinical trials. J Hepatol. 13:1991;192-199.
2. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alfa-2b. Hepatology. 18:1993;1300-1305.
3. Garson JA, Brillanti S, Ring C, Perini M, Barbara L. Hepatitis C viremia rebound after "successful" interferon therapy in patients with chronic non-A, non-B hepatitis. J Med Virol. 37:1992;210-214.
4. Fattovich G, Giustina G, Favarato S. Ruol A and Investigators of the Italian Association for the Study of the Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 24:1996;38-47.
5. Pagliaro L, Craxì A, Cammaà C, Tiné F, Di Marco V, Lo Iacono O, Almasio P. Interferon alfa for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology. 19:1994;820-828.
6. Yoshioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, et al. Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver. 15:1995;57-62.
7. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
8. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, et al. Loss of serum HCV-RNA at week 4 of interferon alpha therapy is associated with more favourable long-term response in patients with chronic hepatitis C. J Med Virol. 46:1995;109-115.
9. Ampurdanès S, Olmedo E, Maluenda MD, Forns X, Lòpez-Labrador FX, Costa J, et al. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. J Hepatol. 25:1996;827-832.
10. Karino Y, Toyota J, Sugawara M, Higashino K, Sato T, Ohmura T, et al. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am J Gastroenterol. 92:1997;61-65.
11. Hino K, Okuda M, Konishi T, Ishiko H, Okita K. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci. 40:1995;14-20.
12. Toyoda H, Kumada T, Nakano S, Takeda I, Sigiyama K, Kiriyama S, et al. Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 9:1997;245-249.
13. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepatology. 24:1996;778-789.
14. Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment. Eur J Gastroenterol Hepatol. 9:1997;1169-1177.
15. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 22:1995;696-699.
16. Chomczynski P, Sacchi N. Simple-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem. 162:1985;156-159.
17. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genoypes in patients with and without liver function abnormalities. Hepatology. 21:1995;285-290.
18. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
19. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
20. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
21. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 74:1993;2385-2390.
22. Simmonds P, Holmes EC, Cha TA, Chan S-W, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 74:1993;2391-2399.
23. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 19:1994;1321-1324.
24. Chemello L, Cavalletto L, Bernardinello E, Guido M, Pontisso P, Alberti A. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol. 23:(Suppl 2):1995;8-12.
25. Lai M-Y, Kao J-H, Yang P-M, Wang J-T, Chen P-J, Chan K-W, et al. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology. 111:1996;1307-1312.
26. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KS, Shieh YSC, et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alpha treatment. Gastroenterology. 104:1993;1472-1477.
27. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Ann Intern Med. 122:1995;586-591.
28. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV-RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology. 18:1993;1050-1054.
29. Berenguer M, Olaso V, Cordoba J, Gobernado M, Carrasco D, Berenguer J. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 7:1995;899-903.
30. Branch AD. Replication of hepatitis C virus: catching it in the act. Hepatology. 23:1996;372-375.